MyFinder is a unique search engine with a simple privacy concept in mind. We log your searches but none of the data, it's that simple.
Bi-specific t-cell engagerChimeric antigen receptor t cellCancer immunotherapyActive immunotherapyMonoclonal antibody therapyCancer immunologyAntibody-drug conjugateTisagenlecleucelTixagevimab/cilgavimabIpilimumabBrigatinibBrexucabtagene autoleucelPembrolizumabBrentuximab vedotinCell therapyTargeted therapyBelataceptAlk inhibitorBamlanivimab/etesevimabIbritumomab tiuxetanTildrakizumabTrastuzumab deruxtecanInotuzumab ozogamicinJurkat cellsTrastuzumab emtansineGemtuzumab ozogamicinRituximabAmivantamabCobimetinibCytotoxic t cellObinutuzumabLeronlimabAtoltivimab/maftivimab/odesivimabT-cell receptorEtanerceptSacituzumab govitecanDracoBinimetinibTnf receptor superfamilyImmunostimulantAvelumabIntegrase inhibitorAtezolizumabReverse-transcriptase inhibitorPanitumumabCancer stem cellTanezumabPertuzumabLoncastuximab tesirineIbrutinibCemiplimabImmunotherapyMidostaurinTigitIdecabtagene vicleucelDarpinTafasitamabInfliximabDabrafenibPatient derived xenograftBelinostatIvosidenibOfatumumabTacstd2OleclumabElotuzumabBasiliximabEmicizumabEverolimusRet inhibitorAbataceptRegulatory t cellRisankizumabCtla-4SiltuximabMonalizumabEnfuvirtideMogamulizumabPlerixaforGene therapyAlectinibTalimogene laherparepvecPalivizumabSipuleucel-tRomidepsinFms-like tyrosine kinase 3 ligandDna vaccineResiquimodIsatuximabEnfortumab vedotinLebrikizumabCheckpoint inhibitorLisocabtagene maraleucelTeniposideCrenezumabTremelimumabGc376SotrovimabImmune complexImmunosuppressive drug